Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fusion Pharmaceuticals Inc. - Common Shares (NQ:FUSN)

21.55 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 21.55
Bid (Size) 21.65 (33)
Ask (Size) 21.87 (1)
Prev. Close 21.55
Today's Range 21.55 - 21.55
52wk Range N/A - N/A
Shares Outstanding 63,846,009
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024 ↗
FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace

Performance

More News

Read More
News headline image
Top 4 Health Care Stocks That May Plunge This Month ↗
Via Benzinga
News headline image
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗
Via Investor's Business Daily
News headline image
Recap: Fusion Pharmaceuticals Q4 Earnings ↗
Via Benzinga
News headline image
Unveiling 11 Analyst Insights On Fusion Pharmaceuticals ↗
Via Benzinga
Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm
Via News Direct
News headline image
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost ↗
Via Benzinga
News headline image
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race ↗
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023 ↗
Via InvestorPlace
News headline image
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results ↗
Via Benzinga
Topics Stocks
News headline image
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results ↗
Via Benzinga
Topics Stocks
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
Topics Stocks
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning
Via Investor Brand Network
News headline image
Nasdaq Down 100 Points; US Housing Starts Surge In February ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover ↗
Via Investor's Business Daily
News headline image
Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today? ↗
Via InvestorPlace
News headline image
Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga

Frequently Asked Questions

Is Fusion Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Fusion Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Fusion Pharmaceuticals Inc. - Common Shares trade on?
Fusion Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Fusion Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Fusion Pharmaceuticals Inc. - Common Shares is FUSN on the Nasdaq Stock Market
What is the current price of Fusion Pharmaceuticals Inc. - Common Shares?
The current price of Fusion Pharmaceuticals Inc. - Common Shares is 21.55
When was Fusion Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Fusion Pharmaceuticals Inc. - Common Shares was at 06/03/24 04:00 PM ET
What is the market capitalization of Fusion Pharmaceuticals Inc. - Common Shares?
The market capitalization of Fusion Pharmaceuticals Inc. - Common Shares is 1.38B
How many shares of Fusion Pharmaceuticals Inc. - Common Shares are outstanding?
Fusion Pharmaceuticals Inc. - Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.